Catalyst Wire Dossier Catalyst Wire Dossier

QRX-3

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QRX-3, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics [Phase 2]

See pricing